登录 注册 会员服务 联系我们

Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder

  • Published:2009-06 Issue:6 Volume:181 Page:2608-2615
  • ISSN:0022-5347
  • Container-title:Journal of Urology
  • language:en
  • Short-container-title:Journal of Urology

Author:

Flynn Michael K.1,Amundsen Cindy L.2,Perevich MaryAnn3,Liu Fan4,Webster George D.5

Affiliation:

1. Division of Urogynecology, Department of Obstetrics and Gynecology, University of Rochester, Rochester, New York

2. Division of Urogynecology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina

3. Department of Urology, Division of Urogynecology, University of Rochester, Rochester, New York

4. Center for Research Epidemiology, Department of Obstetrics and Gynecology, University of Rochester, Rochester, New York

5. Department of Urology, Duke University Medical Center, Durham, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Epidemiology and social impact of urinary and fecal incontinence;Weber,1999

2. Current and future pharmacological treatment for overactive bladder;Yoshimura;J Urol,2002

3. Pharmacology and immunology of botulinum toxin serotypes;Aoki;J Neurol,2001

4. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology;Brin;Muscle Nerve, suppl,1997

5. Botulinum toxin: historical perspective and potential new indications;Jankovic;Muscle Nerve, suppl,1997
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3